Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study page revision label updated from v3.6.2 to v3.6.3, reflecting a minor update to the record without changing substantive content.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page's revision tag in the footer was updated from v3.6.0 to v3.6.2, signaling a small update to the page's underlying version.SummaryDifference0.1%

- Check30 days agoChange DetectedThe study page now shows 'No longer looking for participants' and adds new sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', while removing the old 'Intervention / Treatment' heading and the prior 'Revision: v3.5.5' note.SummaryDifference0.4%

- Check37 days agoChange DetectedThe page's revision indicator updated from Revision: v3.5.4 to Revision: v3.5.5, signaling a minor page refresh.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a minor backend/metadata update to the page. It does not change the core study information presented.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a site revision without changing the underlying study information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.